Extracellular vesicles as drug vectors for precise cancer treatment

Xin-Hui Cao1,2, Ming-Xing Liang1, Yang Wu3

  • 1Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China.

Insights

Extracellular vesicles (EVs) are natural nanocarriers for targeted cancer therapy. This review explores their use in delivering antitumor drugs and nanomaterials for precise cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Extracellular vesicles (EVs) are nano-sized vesicles secreted by cells.
  • EVs carry biomolecules and mediate intercellular communication.
  • They possess unique properties for potential therapeutic applications, including cancer treatment.

Purpose of the Study:

  • To review the applications of EVs as nanocarriers for anticancer drugs and nanomaterials.
  • To summarize EV preparation methods and strategies for enhancing drug loading and targeting.
  • To highlight the potential of EV-based drug delivery in precise cancer therapy.

Main Methods:

  • Literature review of studies on EVs in cancer therapy.
  • Systematic summary of EV preparation techniques.
  • Analysis of methods to improve EV drug loading and cancer targeting.

Main Results:

  • EVs can serve as effective nanocarriers for antitumor drugs, gene drugs, and other anticancer nanomaterials.
  • Various preparation methodologies for EVs are available.
  • Strategies exist to optimize drug loading efficiency and cancer-targeting specificity of EVs.

Conclusions:

  • EV-based drug delivery shows significant promise for precise and effective cancer treatment.
  • Further research into EV preparation and functionalization can enhance their therapeutic potential.
  • EVs represent a promising frontier in the development of next-generation cancer therapies.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
597
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K